USA - engelsk - NLM (National Library of Medicine)

kalchem international inc - pentosan polysulfate sodium (unii: 914032762y) (pentosan polysulfate - unii:f59p8b75r4) -

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

parnell technologies pty ltd - pentosan polysulfate sodium - unknown - pentosan polysulfate sodium mineral-sodium active 0.0 - active constituent

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

nature vet pty ltd, australia - pentosan polysulfate sodium - solution for injection - 250 mg/ml

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ceva animal health pty ltd, australia - pentosan polysulfate sodium - solution for injection - 250 mg/ml

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

chanelle pharmaceuticals manufacturing limited - pentosan polysulfate sodium - unknown - pentosan polysulfate sodium mineral-sodium active 0.0 - active constituent

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - pentosan polysulfate sodium - unknown - pentosan polysulfate sodium mineral-sodium active 0.0 - active constituent

USA - engelsk - NLM (National Library of Medicine)

physician therapeutics llc - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine hydrochloride 10 mg - fluoxetine is indicated for the acute and maintenance treatment of major depressive disorder in adult patients and in pediatric patients aged 8 to18 years [see clinical studies (14.1) ]. the usefulness of the drug in adult and pediatric patients receiving fluoxetine for extended periods should periodically be re-evaluated [see dosage and administration (2.1) ]. fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with obsessive compulsive disorder (ocd)  [see clinical studies (14.2) ]. the effectiveness of fluoxetine in long-term use, i.e., for more than 13 weeks, has not been systematically evaluated in placebo-controlled trials. therefore, the physician who elects to use fluoxetine for extended periods, should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see dosage and administration (2.2) ]. fluoxetine is indicated for the acute and maintenance treatment of bi

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - pentosan polysulphate sodium - solution for injection - 100 milligram(s)/millilitre - pentosan polysulfate sodium

USA - engelsk - NLM (National Library of Medicine)

dechra veterinary products - pentosan polysulfate sodium (unii: 914032762y) (pentosan polysulfate - unii:f59p8b75r4) - horses with hypersensitivity to pentosan polysulfate sodium or any of the inactive ingredients in zycosan should not receive zycosan. do not use zycosan concurrently with other anticoagulant drugs. do not use in horses with clotting disorders or within 24 hours of surgical procedures (see warnings and precautions).

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

biopharm australia pty ltd - pentosan polysulfate sodium - parenteral liquid/solution/suspension - pentosan polysulfate sodium mineral-sodium active 250.0 mg/ml - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - inflammatory joint disease | osteoarthritis | non-infectious joint disease